|
MORE DETAILS
|
WEEKLY COMMENT
|
Every Tuesday we send out the MedComms Networking email newsletter to subscribers. It includes brief commentary on what we're doing and planning, and highlights relevant news to encourage sharing of information, experiences and ideas and to stimulate discussion. The text and links included below, by definition, were accurate on the day of publication, but may then become outdated.
|
|
MedComms Networking - 20 February 2024
Hi
I like to stress how everything I do is listed at MedCommsNetworking.com, but in truth plenty more goes on under the surface. Yesterday was a case in point.
We were invited to talk to the final year Biomedical Sciences students at Aston University about working in and around MedComms. I took Eleanor Steele (aka The MedComms Mentor) and representatives from Avalere Health, IPG Health and Word Monster and a good time was had by all. Hopefully, the students benefited as well!
Next month I'm running an online workshop for Oxford University with some of our FirstMedCommsJob Sponsors. Kudos all.
Then, importantly, our next big open in-person careers event is at Manchester University on 21 March. Please help spread the word and encourage anyone who wants to learn more about our business to join us there. Whether they want to move now, soon, or later into the future, everyone's welcome. The simple fact is lots of people who have attended these events now work in and around #MedComms and meeting in-person helps hugely.
Towards the end of yesterday's session, we were asked the hot current question! "Will AI kill medical writing?"
Everyone was quick to say "No!", but isn't it far more nuanced and plain complicated?
An article was published yesterday in a Springer Journal, Infectious Diseases and Therapy. In the Acknowledgements section of Outcomes of Drug Interactions Between Antiretrovirals and Co-Medications, Including Over-the-Counter Drugs: A Real-World Study is the following statement:
Medical Writing and Editorial Assistance
ChatGPT version 3.5 was used to check for English grammar and style of the final version of the manuscript.
Where once we might have seen thanks given to the human medical writers and editors involved...
Join this LinkedIn discussion I started this morning and share your thoughts. Amongst the many comments that have already appeared, some have been quick to dismiss the AI and emphasise the need for humans to check. But who are we then blaming for the typos? It may be petty of me to point them out, but there's a serious point in there.
Here are some more suggestions to explore.
The recordings from last week's #MedComms webinars are, of course, freely available at NetworkPharma.tv. I reckon The Results of the #MedComms Freelancing Barometer 2024 should provide plenty of food for thought.
This one should be fun for the disruptors. Paul Simms is running Musk Pharma: A Roundtable Debate next week on 28 February.
What about this report in Nature? Lizzie Wolkovich explains how a journal reviewer accused her of using ChatGPT to write a manuscript. She hadn't — but her paper was rejected anyway. Any thoughts, anyone?
Meanwhile, in tomorrow's free #MedComms Webinar, join Daniel Gibbs. Justin Erswell and Eve Guichard, for Achieving true globally aligned sci comms - can tech really help de-silo the pharma industry?
And in next Wednesday's webinar, we'll talk about Working effectively in healthcare communications: Turning stress into a force for good. Join us. It might do you good!
Stay well, everyone. There's lots more coming.
Cheers
Peter Llewellyn
Managing Director, NetworkPharma Ltd
Follow me on LinkedIn @NetworkPharma
Join more than 8,000 international colleagues in the MedComms Networking Linkedin Group
The information at MedCommsNetworking.com is always bang up-to-date!
|
|
|
|
